Company Profiles
Target Profiles
Product Profiles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Company Profiles
Target Profiles
Product Profiles
China Healthcare Summit
Bio€quity Europe
Explore BCIQ profiles by entering a company name.
REQUEST A FREE TRIAL
Overview
Pipeline
Deals
Financings
Earnings Summary
Stock Summary
Articles
Lipigon Pharmaceuticals AB
Headquarters:
Umea, Sweden
Website:
http://www.lipigon.se
Year Founded:
2010
Status:
Public
Industry Sector:
HealthTechnology
CEO:
Johan Liwing
Number Of Employees:
N/A
Enterprise Value:
N/A
PE Ratio:
-0.73
Exchange/Ticker 1:
SSE:LPGO
Exchange/Ticker 2:
N/A
Latest Market Cap:
$5,832,418
BioCentury
|
Nov 1, 2018
Emerging Company Profile
Secarna’s next-gen oligos
Why Secarna is developing antisense oligonucleotides for immuno-oncology
Read More
BioCentury
|
Dec 3, 2012
Emerging Company Profile
Lipigon: LPL protectorate
Lipigon taking new approach to lipoprotein lipase to prevent atherosclerosis
Read More
Items per page:
10
1 - 2 of 2
Help Center
Username
Request Training
Submit Data Correction
Ask a Question
Elevio by Dixa
Help